Dehydroepiandrosterone sulfate decreases the interleukin-2-mediated overactivity of the natural killer cell compartment in senile dementia of the Alzheimer type

Dementia and Geriatric Cognitive Disorders

Volumn 10, Issue 1, 1999, Pages 21-27

  Solerte, Sebastiano Bruno ^a   Fioravanti, Marisa ^a   Schifino, Nicola ^a   Cuzzoni, Gianni ^a   Fontana, Ilaria ^a   Vignati, Giulio ^b   Govoni, Stefano ^a   Ferrari, Ettore ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Ospedale G Fornaroli   (Italy)

Author keywords

Aging; Alzheimer's disease; Dehydroepiandrosterone sulfate; Immunity; Interleukin 2; Magnetic cell sorter; Natural killer cells

Indexed keywords

CYTOKINE; INTERLEUKIN 2; PRASTERONE SULFATE;

AGED; ALZHEIMER DISEASE; ARTICLE; CELLULAR IMMUNITY; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; IMMUNITY; IMMUNOMODULATION; MALE; NATURAL KILLER CELL; NEUROIMMUNOLOGY; PRIORITY JOURNAL; SENILE DEMENTIA;

ADULT; AGED; AGING; ALZHEIMER DISEASE; CIRCADIAN RHYTHM; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; MALE; MONOCYTES;

EID: 0032889058     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017093     Document Type: Article

References (64)

1. Baulieu EE, Corpèchot C, Dray F, Emiliozzi R, Lebeau MC, Mauvaislarvis P, Robel P: An adrenal-secreted 'androgen': Dehydroepiandrosterone sulfate. Its metabolism and a tentative generalization on the metabolism of other steroid conjugates in man. Recent Prog Horm Res 1965;21:411-500.
2. Doouss TW, Skinner SJM, Couch RAF: Synthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate by the human adrenal. J Endocrinol 1975;66:1-12.
3. Rosenfeld RS, Rosenberg BJ, Fukushima DK, Hellman L: 24-hour secretory pattern of dehydroepiandrosterone and dehydroepiandrosterone sulfate. J Clin Endocrinol Metab 1975;40: 850-855.
4. Kalimi M, Regelson W (eds): The Biologic Role of Dehydroepiandrosterone (DHEA). New York, de Gruyter, 1990.
5. Drucker WD, Blumberg JM, Gandy HM, David RR, Verde AL: Biologic activity of dehydroepiandrosterone sulfate in man. J Clin Endocrinol Metab 1972;35:48-54.
6. Ebeling P, Koivisto VA: Physiological importance of dehydroepiandrosterone. Lancet 1994; 343:1479-1481.
7. Barret-Connor E, Khaw KT, Yen SS: A prospective study of dehydroepiandrosterone sulfate, mortality in cardiovascular disease. N Engl J Med 1986;315:1519-1524.
8. De Peretti E, Forest MG: Pattern of plasma dehydroepiandrosterone levels in humans from birth to adulthood: Evidence for testicular production. J Clin Endocrinol Metab 1978; 47:572-577.
9. Orentreich N, Brind JL, Rozer RL, Vogelman JH: Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984;59:551-555.
10. Vermeulen A: Androgen secretion after age 50 in both sexes. Horm Res 1983;18:37-42.
11. Birkenhager-Gillesse EG, Derksen J, Lagaay AM: Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over. Ann NY Acad Sci 1994;719:543-552.
12. Legrain S, Berr C, Frenoy N, Gourlet V, Debuire B, Baulieu EE: Dehydroepiandrosterone sulfate in a long-term care aged population. Gerontology 1995;41:343-351.
13. Barret-Connor E, Edelstein SL: A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: The Rancho Bernardo Study. J Am Geriatr Soc 1994;42:420-423.
14. Sunderland T, Merril CR, Harrington MG, Lawlor BA, Molehan SE, Martinez R, Murphy DL: Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease. Lancet 1989;ii:570.
15. Näsman B, Olsson T, Bäckström T, Eriksson S, Grankvist K, Viitanen M, Bucht G: Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia. Biol Psychiatry 1991;30:684-690.
16. Späth-Schwalbe E, Dodt C, Dittmann J, Schüttler R, Fehm HL: Dehydroepiandrosterone sulfate in Alzheimer's disease. Lancet 1990;i:1412.
17. Leblhuber F, Windhager E, Reisecker F, Steinparz FX, Dienstl E: Dehydroepiandrosterone sulfate in Alzheimer's disease. Lancet 1990;ii: 449.
18. Leblhuber F, Windhager E, Steinpart FX, Dienstl E, Reisecker F, Rittmannsberger H: Dehydroepiandrosterone sulfate serum levels in normal aging and Alzheimer's disease. Age 1991;14:116-118.
19. Schneider LS, Hinsey M, Lyness S: Plasma dehydroepiandrosterone in Alzheimer's disease. Biol Psychol 1992;31:205-208.
20. Regelson W, Loria RM, Kalimi M: Hormonal intervention: 'Buffer hormones' or 'state dependency'. The role of dehydroepiandrosterone (DHEA), thyroid hormone, estrogen and hypophysectomy in aging. Ann NY Acad Sci 1988;521:260-273.
21. Loria RM, Inge TH, Cook S, Szakal A, Regelson W: Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA). J Med Virol 1988;26: 301-314.
22. Daynes RA, Dudley DJ, Araneo BA: Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin-2 synthesis by helper cells. Eur J Immunol 1990;20:793-802.
23. Daynes RA, Araneo BA: Prevention and reversal of some age-associated changes in immunologic responses by supplemental dehydroepiandrosterone-sulfate therapy. Aging Immunol Infect Dis 1992;3:135-152.
24. Daynes RA, Araneo BA: Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factor interleukin 2 and interleukin 4. Eur J Immunol 1990;19:2319-2325.
25. Suzuki T, Suzuki N, Daynes RA, Engleman EG: Dehydroepiandrosterone enhances IL-2 production and cytotoxic effector function of human T-cells. Clin Immunol Immunopathol 1991;61:202-211.
26. Rasmussen KR, Martin EG, Arrowood MJ, Healey MC: Effect of dexamethasone and dehydroepiandrosterone in immunosuppressed rats infected with Cryptosporidium parvum. J Protozool 1991;38:157-159.
27. Araneo BA, Shelby J, Li GZ, Ku W, Daynes RA: Administration of dehydroepiandrosterone to burned mice preserves normal immunologic competence. Arch Surg 1993;128:318-325.
28. Gidlund M, Orn A, Wigzell H, Senik A, Gresser I: Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 1978;273:759-761.
29. Henney CS, Kuribayashi K, Kern DE, Gillis S: Interleukin-2 augments natural killer cell activity. Nature 1981;291:335-337.
30. Albright JW, Albright JF: Age-associated decline in natural killer (NK) activity reflects primarily a defect in function of NK cells. Mech Ageing Dev 1985;31:295-306.
31. Krishnaray R, Blandford G: Age-associated alterations in human natural killer cells. I. Increased activity as per conventional and kinetic analysis. Clin Immunol Immunopathol 1987; 45:268-285.
32. Araga S, Kagimoto H, Funamoko K, Takahashi K: Reduced natural killer cell activity in patients with dementia of the Alzheimer type. Acta Neurol Scand 1991;84:259-263.
33. Lighart GJ, Corberand JX, Geertzen HG, Meinders AE, Knoox DL, Hijmans W: Necessity of the assessment of health status in human immunogerontological studies: Evaluation of the SENIEUR protocol. Mech Ageing Dev 1990;55:89-105.
34. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3 revised. Washington, American Psychiatric Association, 1987.
35. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
36. Hachinski VC, Lassen NA, Mashall J: Multi-infarct dementia: A cause of mental deterioration in the elderly. Lancet 1974;ii:207-210.
37. Folstein M, Folstein S, McHugh PR: Mini Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;2:189-198.
38. Timonen T, Ranki A, Saksele E, Hayry P: Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets. Cell Immunol 1979;48:133-139.
39. Robertson MJ, Ritz J: Biology and clinical relevance of human natural killer cells. Blood 1990;76:2421-2438.
40. Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968;21(suppl):31-50.
41. Julius MH, Simpson E, Herzenberg LA: A rapid method for isolation of functional thymus-derived murine lymphocytes. Eur J Immunol 1973;3:645-649.
42. Miltenyi S, Muller W, Weichel W, Radbruch A: High gradient magnetic cell separation with MACS. Cytometry 1990;11:231-238.
43. Pflüger E, Mueller EA, Anderer FA: Preservation of cytotoxic function during multi-cycle immunomagnetic cell separations of human NK cells using a new type of magnetic bead. J Immunol Methods 1990;129:165-173.
44. Gatti G, Cavallo R, Sartori ML, Del Ponte D, Masera R, Salvadori A, Carignola R, Angeli A: Inhibition by cortisol of human natural killer (NK) cell activity. J Steroid Biochem 1987;26: 49-58.
45. Holbrook NJ, Cox WI, Horner HC: Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocorticoids and its modulation by interferon. Cancer Res 1983;43:4019-4025.
46. Korzeniewski C, Callewaert DM: An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983;64:313-320.
47. Pross HF, Baynes MG, Rubin P, Shragge P, Patterson MS: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantification of natural killer cell activity. J Clin Immunol 1981;1:51-63.
48. Halberg F: Chronobiology. Annu Rev Physiol 1969;31:675-725.
49. De Neve L, Vermeulen A: The determination of 17 oxosteroidsulfates in human plasma. J Endocrinol 1965;32:295-302.
50. Solerte SB, Fioravanti M, Severgnini S, Locatelli M, Renzullo M, Pezza N, Cerutti N, Ferrari E: Enhanced cytotoxic response of natural killer cells to interleukin-2 in Alzheimer's disease. Dementia 1996;7:343-348.
51. Solerte SB, Fioravanti M, Severgnini S, Cerutti N, Locatelli M, Terenzi F, Cottinelli M, Pezza N, Ferrari E: Cortisol, DHEA-sulfate and natural killer (NK) cell function in the clinical characterization of Alzheimer's disease. J Endocrinol Invest 1996;19(suppl 5):52.
52. Solerte SB, Fioravanti M, Severgnini S, Pezza N, Locatelli M, Cerutti N, Terenzi F, Ferrari E: Excitatory pattern of gamma-interferon on natural killer cell activity in senile dementia of the Alzheimer type. Dement Geriatr Cogn Disord 1997;8:308-313.
53. Solerte SB, Fioravanti M, Severgnini S, Cerutti N, Locatelli M, Ferrari E: Variability of natural killer (NK) cell immune function in normal aging and senile dementia: Pathophysiological implications. Aging (Milano) 1997;9(suppl 4): 32-33.
54. Solerte SB, Fioravanti M, Pascale A, Ferrari E, Govoni S, Battaini F: Increased natural killer cell cytotoxicity in Alzheimer's disease may involve protein kinase C dysregulation. Neurobiol Aging 1998;19:191-199.
55. Solerte SB, Cerutti N, Severgnini S, Rondanelli M, Ferrari E, Fioravanti M: Decreased immunosuppressive effect of cortisol on natural killer cytotoxic activity in senile dementia of the Alzheimer type. Dement Geriatr Cogn Disord 1998;9:149-156.
56. Miller AE, Neighbour PA, Katzman R, Aronson M, Lipkowitz R: Immunological studies in senile dementia of the Alzheimer type: Evidence for enhanced suppressor cell activity. Ann Neurol 1981;10:506-510.
57. Rogers J, Luber-Narod J, Styren SD, Civin WH: Expression of immune system-associated antigens by cells of human central nervous system: Relationship to the pathology of Alzheimer's disease. Neurobiol Aging 1988;9:339-349.
58. Huberman M, Shalit F, Roth-Deri I, Gutman B, Brodie C, Kott E, Sredini B: Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage. J Neuroimmunol 1994;52:147-152.
59. McGeer PL, Rogers J, McGeer EG: Neuroimmune mechanisms in Alzheimer disease pathogenesis. Alzheimer Dis Assoc Disord 1994;8: 149-158.
60. Singh VK: Neuroautoimmunity: Pathogenetic implications for Alzheimer's disease. Gerontology 1997;43:79-94.
61. McRae A, Dahlström A, Ling EA: Microglial neurodegenerative disorders: Emphasis on Alzheimer's disease. Gerontology 1997;43:95-108.
62. Tapson VF, Boni-Schnetzler M, Pilch PF, Center DM, Berman JS: Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor 1 in vitro. J Clin Invest 1988;82:950-957.
63. Yen SS, Morales AJ, Khorram O: Replacement of DHEA in aging men and women. Potential remedial effects. Acad Sci 1995;774:128-142.
64. Kooijman R, Willems M, Dettass CJC, Rijkers GT, Schwurmans ALG, Van Buul-Offers SC, Heijnen CJ, Zegers BJM: Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells. Endocrinology 1992;131:2244-2250.